In addition, although the molecular mechanism is not well understood, there is evidence that CD99 contributes to Ewing sarcoma growth: CD99 knockdown in Ewing sarcoma cells inhibited anchorage-dependent and anchorage-independent growth, and reduced tumorigenicity (Rocchi et al., 2010). The gene discussed is CD99; the disease is Ewing sarcoma.